Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2014
02/20/2014WO2014027361A1 A growth factor concentrate for treating periorbital hyperpigmentation
02/20/2014WO2014027360A1 A growth factor concentrate for treating facial wrinkles
02/20/2014WO2014027359A1 A growth factor concentrate for treating tendinopathies
02/20/2014WO2014026905A1 Complex-specific antibodies and antibody fragments and its use
02/20/2014WO2014026457A1 Industrial preparation of natural killer cells (nks) and injection using human allogeneic karyocytes
02/20/2014WO2014026286A1 Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin
02/20/2014WO2013186630A3 Humanized antibodies to ca215
02/20/2014WO2013183032A3 Humanized anti-trka antibodies with amino acid substitutions
02/20/2014WO2013177062A3 Methods for improving safety of blood-brain barrier transport
02/20/2014WO2013173761A3 St2 antigen binding proteins
02/20/2014WO2012162068A3 Deimmunized serum-binding domains and their use for extending serum half-life
02/20/2014US20140051839 Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation Factors
02/20/2014US20140051838 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
02/20/2014US20140051837 Axmi-205 pesticidal gene and method for its use
02/20/2014US20140051836 Modified Fc Proteins Comprising Site-Specific Non-Natural Amino Acid Residues, Conjugates of the Same, Methods of Their Preparation and Methods of Their Use
02/20/2014US20140051835 Process and Methods for Efficient Manufacturing of Highly Pure Asymmetric Antibodies in Mammalian Cells
02/20/2014US20140051834 Incretin Receptor Ligand Polypeptide Fc-Region Fusion Polypeptides And Conjugates With Altered Fc-Effector Function
02/20/2014US20140051833 Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format
02/20/2014US20140051145 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
02/20/2014US20140051143 Polypeptides Having Cellobiohydrolase I Activity and Polynucleotides Encoding Same
02/20/2014US20140051142 Polypeptides Having Cellobiohydrolase I Activity and Polynucleotides Encoding Same
02/20/2014US20140051124 Methods for reducing accumulation of lactate during culturing and method for producing polypeptide
02/20/2014US20140051120 Humanized anti-egfl7 antibodies and methods using same
02/20/2014US20140051084 Methods and compositions for monitoring phagocytic activity
02/20/2014US20140050754 Immunogenic chikungunya virus peptides
02/20/2014US20140050743 Binding proteins to inhibitors of coagulation factors
02/20/2014US20140050738 Anti-tace antibody molecules and their uses
02/20/2014US20140050736 Chemokine receptor binding polypeptides
02/20/2014US20140050735 Treatment of fistulizing chrohn's disease
02/20/2014US20140050734 Antibodies against the s100p protein for the treatment and diagnosis of cancer
02/20/2014US20140050733 Apoe immunotherapy
02/20/2014US20140050732 Combination for use in the treatment and/or prevention of mastitis
02/20/2014US20140050731 Vaccine
02/20/2014US20140050729 Methods for treatment of polyposis
02/20/2014US20140050727 Anti-cd14 antibody fusion protein
02/20/2014US20140050726 Methods and Compositions for Modulating T Cell and/or B Cell Activation
02/20/2014US20140050725 Low density lipoprotein - related protein 6 (lrp6) - half life extender constructs
02/20/2014US20140050723 Cell-Penetrating Anti-DNA Antibodies and Uses Thereof Inhibit DNA Repair
02/20/2014US20140050722 Chimeric anti-ricin antibody
02/20/2014US20140050720 Ultralong complementarity determining regions and uses thereof
02/20/2014US20140050719 Antibodies
02/20/2014US20140050708 Compositions and Methods for Treating Cancer
02/20/2014US20140050661 Novel anti-cxcr4 antibodies and their use for the treatment of cancer
02/20/2014US20140050660 T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
02/20/2014CA2874864A1 T-cell redirecting bispecific antibodies for treatment of disease
02/19/2014EP2698634A1 Biomarker for breast cancer
02/19/2014EP2698431A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
02/19/2014EP2698386A1 Fusion protein
02/19/2014EP2698385A1 Detection of synthetic cannabinoids
02/19/2014EP2698384A1 Detection of synthetic cannabinoids
02/19/2014EP2698383A1 Detection of synthetic Cannabinoids
02/19/2014EP2698382A1 Human immune therapies using a CD27 agonist alone or in combination with other immune modulators
02/19/2014EP2698381A1 Antibody, kit and method for determining amyloid peptides
02/19/2014EP2698380A1 Neutralizing molecules to viral antigens
02/19/2014EP2698165A1 Cytotoxic immunoglobulin
02/19/2014EP2697260A1 Anti- il-1r1 inhibitors for use in cancer
02/19/2014EP2697259A1 Compositions for preventing and/or treating an infection by an hiv-1 virus
02/19/2014EP2697258A1 Compositions and methods for the alteration of xlhed phenotypes
02/19/2014EP2697257A2 Fc fusion proteins comprising novel linkers or arrangements
02/19/2014EP2696895A1 IMMUNOAFFINITY SEPARATION MATERIALS COMPRISING ANTI-IgE ANTIBODY DERIVATIVES
02/19/2014CN1729203B Human monoclonal antibodies against CD20
02/19/2014CN103597357A Diagnostic use of prosomatostatin
02/19/2014CN103596985A Human monoclonal antibodies specific for glypican-3 and use thereof
02/19/2014CN103596984A Anti-human EPO receptor antibodies and methods of use
02/19/2014CN103596983A Anti-FGFR4 antibodies and methods of use
02/19/2014CN103596982A Therapeutic antibodies
02/19/2014CN103596981A Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
02/19/2014CN103596980A FGFR1 agonists and methods of use
02/19/2014CN103596979A Antibodies to CD70
02/19/2014CN103596978A Anti-IL-12/IL-23 antibodies and uses thereof
02/19/2014CN103596977A Bispecific binding molecules binding to Dll4 and Ang2
02/19/2014CN103596976A Antibody binding to ABCA1 polypeptide
02/19/2014CN103596975A Recombinant human bivalent diabody against rabies virus and uses thereof
02/19/2014CN103596593A Anti-CD40 antibodies and uses thereof
02/19/2014CN103596591A Treatment of osteoarthritis and pain
02/19/2014CN103592439A Human urothelial carcinoma specific antibody and application thereof
02/19/2014CN103592436A A-type H1 subtype influenza virus antibody blocking ELISA kit and applications thereof
02/19/2014CN103589690A Chicken interleukin-18 monoclonal antibody as well as preparation method and application thereof
02/19/2014CN103589689A PSA (prostate specific antigen) monoclonal antibodies and hybridoma cell strains with function of secreting antibodies
02/19/2014CN103589688A Monoclonal antibody resistant to three organophosphorus pesticides and application thereof
02/19/2014CN103589687A Tetrodo toxin neutralizing monoclonal antibody 5E7 hybridomas, genes of light-chain and heavy-chain variable regions thereof and applications
02/19/2014CN103588882A Anti-idiotype antibody for human CD22 antibody, and application thereof
02/19/2014CN103588881A Targeted binding agents directed to PDGFR-alpha and uses thereof
02/19/2014CN103588880A Compositions and methods for regulating NK cell activity
02/19/2014CN103588879A Monoclonal antibody for special identification of recombinant porcine interferon alpha and ELISA kit preparation method
02/19/2014CN103588878A Humanized anti-human-interleukin-1[belta] monoclonal antibody, preparation thereof and applications thereof
02/19/2014CN103588877A Method for purifying soluble antibody
02/19/2014CN103588876A Method used for producing humanized antibodies or antigen combination fragments
02/19/2014CN103588875A Anti-Listeria monocytogenes Listeriolysin O monoclonal antibody and applications
02/19/2014CN103588874A Human anti-HBV surface antigen genetic engineering antibody, and preparation method and application thereof
02/19/2014CN103583841A Anti-goat-ecthyma antibody feed additive and preparation method thereof
02/19/2014CN103007280B Piglet colibacillosis lyophilized serum immunoglobulin preparation and preparation process thereof
02/19/2014CN102643786B Monoclonal antibody of glyphosate-resistant protein G2-aroA and application thereof
02/19/2014CN102584957B Specific antibody of Brucella specificity multi-epitope artificial polypeptide, immunomagnetic beads coated with specific bodies, and application of beads
02/19/2014CN102282172B Anti-extended type i glycosphingolipid antibody, derivatives thereof and use
02/19/2014CN102241771B Duck egg yolk antibody for preventing and treating virus hepatitis of duckling, and preparation method thereof
02/19/2014CN102050879B Anti-human CD20 humanized antibody and preparation method and application thereof
02/19/2014CN101605814B Engineered anti-TSLP antibody
02/18/2014US8653244 Anti-epidermal growth factor receptor antibodies and uses thereof
02/18/2014US8653243 Pertussis antibodies and uses thereof
1 ... 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... 1494